Filing Details
- Accession Number:
- 0000899243-20-003818
- Form Type:
- 5
- Zero Holdings:
- No
- Publication Time:
- 2020-02-10 16:20:28
- Reporting Period:
- 2019-12-31
- Accepted Time:
- 2020-02-10 16:20:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1042418 | Inhibitor Therapeutics Inc. | INTI | Services-Commercial Physical & Biological Research (8731) | 541641133 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1612372 | Mark W. Watson | C/O Inhibitor Therapeutics, Inc. 4830 W. Kennedy Blvd., Suite 600 Tampa FL 33609 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-12-12 | 500 | $0.06 | 1,054,100 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
